Skip to main content

498.01 - Acute Plasma Burn Injury

Classification: Priority Medical Emergency

INDICATION

Treatment of thermal and energy burns resulting from:

  • Plasma conduit ruptures
  • Phaser discharge incidents
  • Warp core coolant exposure
  • EPS grid overload incidents

INITIAL HISTORY & ASSESSMENT

Required History:

  • Time and duration of exposure
  • Type of plasma/energy source involved
  • Confined space exposure (Y/N)
  • Personal protective equipment in use
  • Current medication list
  • Previous plasma exposure history
  • Known allergies to standard treatments
  • Last tetanus prophylaxis (if Earth-origin patient)

Primary Survey:

  1. Vital Signs:
    • Standard vitals (HR, BP, RR, Temperature)
    • Oxygen saturation
    • Neurological status
    • Pain score (0-10)
  2. Tricorder Assessment:
    • Burn depth classification
    • Percentage of body surface area affected
    • Energy residue contamination levels
    • Tissue perfusion status
    • Cellular degradation rate
  3. Visual Inspection:
    • Color changes
    • Presence of blistering
    • Signs of carbonization
    • Circumferential involvement
    • Entrance/exit points (for electrical burns)

DIFFERENTIAL DIAGNOSES

  1. Primary Considerations:
    • Standard plasma thermal burn
    • Radiation burn with plasma exposure
    • Electrical burn with plasma involvement
    • Chemical burn with plasma contamination
  2. Secondary Considerations:
    • Inhalation injury
    • Compartment syndrome
    • Neurological involvement
    • Vascular compromise
    • Deep tissue necrosis

TREATMENT PROTOCOL

Immediate Interventions:

  1. Cryogenic Coolant Gel (CCG-7) Application
    • Reasoning: Halts tissue necrosis progression
    • Application: 2mm thick layer to affected area
    • Duration: Leave in place for 10 minutes
    • Monitor: Temperature gradient every 2 minutes
  2. Pain Management
    • Primary: Hypospray 2mg tetrodotoxin derivative (SF#45-A)
    • Reasoning: Rapid onset, minimal systemic effects
    • Alternative: 1mg trianaline for tetrodotoxin-sensitive species
    • Monitor: Pain scores q15 minutes

Secondary Interventions:

  1. Wound Decontamination
    • Sterile neutronic field at 2.5 MHz
    • Duration: 3 minutes per 10cm² affected area
    • Endpoint: Zero energy residue on tricorder scan
  2. Tissue Regeneration - 499.01 - Dermal Regenerator Operation
    • Epidermal Burns: Dermal regenerator (0.5μm wavelength)
    • Dermal Burns: Biobed collagen synthesis (15-minute cycle)
    • Subdermal Burns: Sequential layered regeneration
    • Duration: Based on depth and surface area

Fluid Resuscitation:

  • Standard: Modified Tantooie Formula for plasma burns
  • 4mL × kg body weight × % burn surface area
  • First half in initial 8 hours
  • Remaining volume over next 16 hours

CONTRAINDICATIONS

  1. Absolute:
    • Regenerator use on contaminated wounds
    • CCG-7 on exposed neural tissue
    • Tetrodotoxin in Vulcanoid species
  2. Relative:
    • Biobed synthesis in pregnancy
    • Neutronic field near cardiac devices
    • Cryogenic treatment in hypothermic patients

MONITORING & FOLLOW-UP

  1. Short-term Monitoring:
    • Vital signs q15 minutes for first hour
    • Wound assessment q1 hour
    • Pain scores with vital signs
    • Tissue perfusion monitoring
  2. Documentation Requirements:
    • Initial wound imaging
    • Treatment response metrics
    • Regeneration cycle completion data
    • Energy residue clearance confirmation

DISCHARGE CRITERIA

  • Zero energy residue on final scan
  • Pain controlled with oral analgesia
  • Full range of motion preserved/restored
  • No signs of infection or necrosis
  • Patient educated on warning signs
  • Follow-up appointment scheduled
No Comments
Back to top